wiki.sine.space | sinespace

Implications for radioresistance mechanisms in head and neck cancer. Lancet Oncol

From wiki.sine.space
Jump to: navigation, search

Stegeman H, Kaanders JH, Wheeler DL, van der Kogel AJ, Verheijen MM, Waaijer SJ, Iida M, Grenman R, Span PN, Bussink J: Finafloxacin Solvent activation of AKT by hypoxia: a possible target for hypoxic tumors in the head and neck. Raju U, Riesterer O, Wang ZQ, Molkentine DP, Molkentine JM, Johnson FM, Glisson B, Milas L, Ang KK: Dasatinib, a multi-kinase inhibitor increased radiation sensitivity by interfering with nuclear localization of epidermal growth factor receptor and by blocking DNA repair pathways. Radiother Oncol 2012, 105:241?49. Stegeman H, Kaanders JH, Wheeler DL, van der Kogel AJ, Verheijen MM, Waaijer SJ, Iida M, Grenman R, Span PN, Bussink J: Activation of AKT by hypoxia: a prospective target for hypoxic tumors in the head and neck. BMC Cancer 2012, 12:463. Davies SP, Reddy H, Caivano M, Cohen P: Specificity and mechanism of action of some usually made use of protein kinase inhibitors. Biochem J 2000, 351:95?05. Marwarha G, Prasanthi JR, Schommer J, Dasari B, Ghribi O: Molecular interplay in between leptin, insulin-like growth factor-1, and beta-amyloid in organotypic slices from rabbit hippocampus. Mol Neurodegener 2011, 6:41. Moynihan B, Tolloczko B, Michoud MC, Tamaoka M, Ferraro P, Martin JG: MAP kinases mediate interleukin-13 effects on calcium signaling in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2008, 295:L171 177. Roux PP, Blenis J: ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev 2004, 68:320?44. Toulany M, Kasten-Pisula U, Brammer I, Wang S, Chen J, Dittmann K, Baumann M, Dikomey E, Rodemann HP: Blockage of epidermal growth element receptor-phosphatidylinositol 3-kinase-AKT signaling increases radiosensitivity of K-RAS mutated human tumor cells in vitro PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/27385778 by affecting DNA repair. Clin Cancer Res 2006, 12:4119?126. Kang KB, Zhu C, Wong YL, Gao Q, Ty A, Wong MC: Gefitinib radiosensitizes stem-like glioma cells: inhibition of epidermal growth aspect receptorAkt-DNA-PK signaling, accompanied by inhibition of DNA double-strand break repair. Int J Radiat Oncol Biol Phys 2012, 83:e43 52. Wheeler DL, Dunn EF, Harari PM: Understanding resistance to EGFR inhibitors-impact on future treatment approaches. Nat Rev Clin Oncol 2010, 7:493?07. Chandarlapaty S, Sawai A, Scaltriti M, Rodrik-Outmezguine V, Grbovic-Huezo O, Serra V, Majumder PK, Baselga J, Rosen N: AKT inhibition relieves feedback suppression of receptor tyrosine kinase expression and activity. Cancer Cell 2011, 19:58?1. Turke AB, Song Y, Costa C, Cook R, Arteaga CL, Asara JM, Engelman JA: MEK inhibition results in PI3K/AKT activation by relieving a adverse feedback on ERBB receptors. Cancer Res 2012, 72:3228?237. Summy JM, Gallick GE: Src family members kinases in tumor progression and metastasis. Cancer Metastasis Rev 2003, 22:337?58. Yeatman TJ: A renaissance for SRC. Nat Rev Cancer 2004, PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/25447644 four:470?80. Kim MJ, Byun JY, Yun CH, Park IC, Lee KH, Lee SJ: c-Src-p38 mitogenactivated protein kinase signaling is essential for Akt activation in response to ionizing radiation. Mol Cancer Res 2008, six:1872?880.